Search Results 681-690 of 17568 for Assay

  1. A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Isatuximab in Patients With Multiple Myeloma - Mayo Clinic

    About this study. Primary Objective: - Part A: To evaluate the safety of SAR650984 (isatuximab) in patients with relapsed/refractory multiple myeloma (RRMM) ...

  2. Ponatinib Hydrochloride in Treating Patients With Advanced Biliary Cancer With FGFR2 Fusions - Mayo Clinic

    ... assays] or FGFR pathway mutation/amplification [using next-gen sequencing assays (such as Foundation One)]; assays must be performed in a Clinical ...

  3. Spinal stenosis - Doctors and departments - Mayo Clinic

    This condition narrows the amount of space within the spine. This can squeeze the nerves that travel through the spine. Surgery is sometimes needed.

  4. Clinical trials - Oncology (Medical)

    ... assays using patient peripheral blood immune cells or serum. Evaluate REC-4881 in Patients With FAP (TUPELO). Scottsdale/Phoenix, Ariz., Rochester, Minn. The ...

  5. Emicizumab in Patients With Acquired Hemophilia A - Mayo Clinic

    ... assay research for emicizumab. Emicizumab reduced the annualized bleeding ... assay by their ability to neutralize FVIII in normal human plasma.

  6. Pharmacogenomics in patient care - Center for Individualized Medicine - Mayo Clinic Research

    The Mayo Clinic Center for Individualized Medicine offers pharmacogenomic testing to better understand how your genes affect your body's response to ...

  7. Clinical trials - Oncology (Medical)

    ... assays using patient peripheral blood immune cells or serum. Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor ...

  8. A Study to Evaluate Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer - Mayo Clinic

    ... assay (e.g., Abbott, Hybritech) within 120 days prior to registration - Study entry PSA should not be obtained during the following time frames: - Ten-day ...

  9. Clinical trials - Oncology (Medical)

    cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...

  10. A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Anti-N-Methyl-D-Aspartic Acid Receptor (NMDAR) Or Anti-Leucine-Rich Glioma-Inactivated 1 (LGI1) Encephalitis (Cielo) - Mayo Clinic

    ... assay within 9 months of symptom onset * Historically known positivity to an intracellular antigen with high cancer association or GAD-65 * Historically ...